Open Access

MicroRNA‑144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C‑X‑C motif chemokine ligand 11

  • Authors:
    • Bin Han
    • Dan Feng
    • Xin Yu
    • Yuanqi Liu
    • Ming Yang
    • Fei Luo
    • Liming Zhou
    • Fu Liu
  • View Affiliations

  • Published online on: July 2, 2018     https://doi.org/10.3892/etm.2018.6389
  • Pages: 1935-1943
  • Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colorectal cancer (CRC) is one of the most common malignancies worldwide. The aim of the present study was to investigate the expression of microRNA‑144 (miR‑144) and C‑X‑C motif chemokine ligand 11 (CXCL11) in CRC and their association. Data from Gene Expression Omnibus (GEO) DataSets were analyzed to obtain the expression profile of CXCL11 in CRC. Subsequently, serum samples were collected from 65 subjects, including 39 patients with CRC and 26 controls; CRC and adjacent normal tissues were collected from all 39 CRC patients and the expression of CXCL11 was measured in these specimens. After searching for the potential regulator of CXCL11 through bioinformatics analysis, the levels of miR‑144 in the clinical specimens were also detected. Finally, the regulatory association between miR‑144 and CXCL11 was certified via the dual‑luciferase reporter assay. Microarray data and bioinformatics analysis demonstrated that CXCL11 was significantly upregulated in CRC tissues and miR‑144 was a potential regulator of CXCL11. In line with this finding, the expression of CXCL11 was significantly increased in the serum and tumor samples of patients with CRC, while that of miR‑144 was downregulated. Dual‑luciferase reporter assay revealed that miR‑144 directly targets the 3'‑untranslated region of CXCL11 mRNA to regulate its expression. These results demonstrated that enhanced CXCL11 expression in patients with CRC was associated with reduced miR‑144 expression. The results of the present study may indicate a novel regulatory role of miR‑144 in CRC through CXCL11 downregulation.
View Figures
View References

Related Articles

Journal Cover

September-2018
Volume 16 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Han B, Feng D, Yu X, Liu Y, Yang M, Luo F, Zhou L and Liu F: MicroRNA‑144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C‑X‑C motif chemokine ligand 11 . Exp Ther Med 16: 1935-1943, 2018.
APA
Han, B., Feng, D., Yu, X., Liu, Y., Yang, M., Luo, F. ... Liu, F. (2018). MicroRNA‑144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C‑X‑C motif chemokine ligand 11 . Experimental and Therapeutic Medicine, 16, 1935-1943. https://doi.org/10.3892/etm.2018.6389
MLA
Han, B., Feng, D., Yu, X., Liu, Y., Yang, M., Luo, F., Zhou, L., Liu, F."MicroRNA‑144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C‑X‑C motif chemokine ligand 11 ". Experimental and Therapeutic Medicine 16.3 (2018): 1935-1943.
Chicago
Han, B., Feng, D., Yu, X., Liu, Y., Yang, M., Luo, F., Zhou, L., Liu, F."MicroRNA‑144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C‑X‑C motif chemokine ligand 11 ". Experimental and Therapeutic Medicine 16, no. 3 (2018): 1935-1943. https://doi.org/10.3892/etm.2018.6389